By Kate Madden Yee, staff writer
November 12, 2013

Sunday, December 1 | 10:55 a.m.-11:05 a.m. | SSA01-02 | Arie Crown Theater
3D ultrasound is a reliable imaging technique for the detection and classification of benign and malignant breast tumors, according to Dutch researchers.

In this Sunday morning scientific session, Dr. Matthieu Rutten, of Jeroen Bosch Hospital, and colleagues will present results from a study they conducted to compare the performance of 3D ultrasound and breast MRI.

For the study, 221 patients underwent 1.5-tesla MRI and 3D ultrasound. The 3D ultrasound findings were reviewed by two radiologists blinded to histopathological diagnoses and prior imaging findings such as mammography, handheld 2D ultrasound, and MRI.

3D ultrasound was successful in 220 patients (one patient was excluded due to a data transfer mistake), and each breast was evaluated with three to five scans. Overall exam time was 15 to 20 minutes per patient.

3D ultrasound identified 194 benign and 43 malignant breast tumors, while MRI found 191 benign and 46 malignant lesions, leading Rutten's group to conclude that the technology can reliably be used in a clinical setting.